Full-Time

Sales Associate

Sports Medicine

Posted on 9/15/2025

Stryker

Stryker

10,001+ employees

Manufactures orthopedic and surgical medical devices

No salary listed

Solihull, UK + 2 more

More locations: Derby, UK | Birmingham, UK

Hybrid

The role covers the East and West Midlands, including but not limited to Birmingham, Derby, Rugby, and Cannock.

Category
Medical, Clinical & Veterinary (1)
Required Skills
Sales
Customer Service
Requirements
  • Would be ideal if you had some sales or business experience
  • Degree related to Science/ Sports would be desirable, or equivalent experience
  • Commercial acumen, an interest or experience of dealing with customers would be beneficial
  • Computer skills, MS Office
  • Presentation skills with modern presentation media
  • Workshop/demonstration skills/training skills/presentation skills
  • An interest in anatomy and physiology
  • A background that demonstrates an ability to engage with others, influence, motivate and work hard
Responsibilities
  • Develop the skills required to become an effective Sales Representative.
  • Learning and practicing the techniques required to grow the volume of a defined territory through sales of Stryker Sports Medicine products.
  • Learn to manage business in accounts within an existing sales territory and become responsible for the day to day running of key accounts.
  • Become proficient in dealing with; stock issues, instrument requirements, organising loan kits, organising and carrying out regular customer training, learning to provide guidance on the safe use of Stryker products within the defined portfolio in the hospital and operating theatre environment.
  • Supporting other sales managers to allow them to concentrate on new business acquisition, new account development.
  • Learning the skills required to manage a territory effectively and grow business in line with National sales objectives.
  • Learn how to implement training sessions and workshops on the use of Stryker products. Deliver these sessions to nurses, theatre practitioners and surgeons.
  • Learn how to gain an understanding of customers’ needs and identify the opportunity to promote and sell Stryker’s products. Training will be given on basic selling, presenting and negotiation techniques.
  • Gain an understanding of the different ways to provide product into a hospital through consignment of kit or use of our loan service and learn to manage these channels to best suit our customer’s needs.
  • Provide customer service to an existing customer base within the theatre and clinical environment. This will involve a specific set of hospitals where the candidate will have day to day communication and need to respond promptly to requests from customers in those hospitals. The candidate will be required to build relationships with key personnel in these hospitals.
  • At all times appreciate that provision of appropriate medical care for the patient is of paramount importance and our priority is to only ever recommend product that is appropriate.
  • Working closely with other Sales team members within the defined region, and the Regional Business Manager, to ensure customer service levels are best in class across that region. Attend surgeon training meetings and educational conferences.
  • Demonstrate outstanding ethics at all times. Treat customers and other employees with respect. Represent Stryker in the best possible light.
  • Learn how to conduct trials and evaluations of product in theatre and clinical environment as required.
  • Make observations of customer needs and liaise with sales colleagues to follow up on and introduce new or additional Stryker product and/or support.
  • Learn to record details of customers and maintain a basic business plan highlighting daily, weekly and monthly objectives. Start to develop the skills needed to prioritise where to allocate time and resource and how to grow business.
Desired Qualifications
  • Degree related to Science/ Sports would be desirable, or equivalent experience
  • Would be ideal if you had some sales or business experience

Stryker designs, manufactures, and sells medical devices across multiple areas, including surgical equipment, neurotechnology, and orthopedic implants, to hospitals and clinics worldwide. Its products are developed through engineering and clinical input, then manufactured and distributed to healthcare providers who use them during procedures to improve patient care and surgical efficiency. Stryker differentiates itself from competitors with a broad, integrated portfolio, a global sales and service network, and a strong emphasis on quality and ongoing product development to support safer, more efficient procedures. The company’s goal is to advance patient outcomes by delivering reliable, effective medical devices that expand access to care globally.

Company Size

10,001+

Company Stage

IPO

Headquarters

Kalamazoo, Michigan

Founded

1941

Simplify Jobs

Simplify's Take

What believers are saying

  • Robotic surgery leadership drives double-digit sales growth through 2025.
  • India Trident II launch targets aging population's rising hip surgeries.
  • Peripheral vascular expansion via IVL meets growing arterial disease demand.

What critics are saying

  • Handala cyberattack on March 11 delays ortho supply chain 3-6 months.
  • Zimmer Biomet Persona IQ erodes ortho share with real-time analytics.
  • J&J Velys captures 25% more knee procedures from Mako in 6-12 months.

What makes Stryker unique

  • Stryker holds 39.1% US market share in orthopedic product manufacturing.
  • Trident II Acetabular System integrates Mako SmartRobotics for hip replacements.
  • Amplitude Vascular Systems acquisition adds CO₂ IVL for peripheral arteries.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Medical & prescription plans

Supplemental health benefits

Flexible Spending accounts

Employee Assistance Program

Short-term & long-term disability

Tuition reimbursement

401(k) plan

Employee Stock Purchase Plan

Company News

ASC News
Apr 13th, 2026
ASC Technology Roundup: Distalmotion Files for Expanded Robotic Gynecology Clearance; Stryker, Medtronic Make Acquisitions

Distalmotion targets ASC gynecology programs with new FDA filing Distalmotion has submitted a 510(k) application to the FDA seeking to expand the label of its Dexter robotic surgery system into additional gynecological indications, the company announced April 1. The filing covers sacrocolpopexy, sacrocervicopexy and endometriosis resection. Sacrocolpopexy and sacrocervicopexy are procedures used to treat pelvic…

Market Wire News
Apr 13th, 2026
Stryker to acquire Amplitude Vascular Systems, adding next-gen IVL tech to peripheral vascular portfolio

Stryker Corporation has signed a definitive agreement to acquire Amplitude Vascular Systems, a Boston-based medical technology company developing next-generation intravascular lithotripsy technology for treating calcified peripheral arterial disease. Financial terms were not disclosed. AVS's technology uses pulsed CO₂-generated pressure waves delivered through a balloon catheter to fracture calcium deposits. The platform aims to enhance catheter deliverability, treatment speed and therapy efficiency. The acquisition will strengthen Stryker's peripheral vascular portfolio and expand its presence in arterial disease treatment. Stryker CEO Kevin Lobo said the deal advances the company's vision to build a comprehensive peripheral vascular platform addressing significant clinical needs. IVL technology is experiencing strong growth as physicians increasingly adopt it for calcium modification in complex cardiovascular procedures. The transaction remains subject to customary closing conditions.

Yahoo Finance
Mar 18th, 2026
Stryker posts 11% Q4 growth amid tariff pressures, margin expansion continues

Stryker has raised $120 million in a Series C round led by Ribbit Capital, valuing the medical technology company at $1.45 billion. The funding comes despite shares declining 7.6% over the past six months, outperforming the industry's 19.7% drop. The company delivered 11% organic sales growth in Q4 2025 and 10.3% for the full year, marking its fourth consecutive year of double-digit growth. Performance was broad-based across its Orthopaedics, MedSurg and Neurotechnology segments, driven by strong procedural volumes and favourable demographics. Stryker achieved over 100 basis points of operating margin expansion for the second consecutive year despite tariff pressures. The company enters 2026 with a robust capital equipment backlog, though rising interest costs and tariffs present near-term challenges. Analysts maintain a Hold rating on the stock.

Yahoo Finance
Mar 13th, 2026
Stryker shares fall 9% to $339 after Iranian cyberattack wipes 200,000+ systems

Stryker shares fell 9% to $339 following a destructive cyberattack by Iranian-linked group Handala that wiped over 200,000 systems and disrupted manufacturing and shipping operations across 56,000 employees in 61 countries. The medical technology company confirmed disruptions to order processing but stated there was no indication of ransomware. Unlike typical ransomware attacks, this wiper attack permanently deleted data rather than holding it for ransom, complicating recovery efforts. The incident threatens Stryker's 8% to 9.5% organic growth guidance for 2026 if operations fail to normalise quickly. Stryker generated $25 billion in revenue in 2025 with $4.283 billion in free cash flow and holds $4 billion in cash. Analysts maintain a consensus price target of $424.89 with 22 buy ratings and no sell ratings among 30 covering analysts.

Yahoo Finance
Mar 12th, 2026
Stryker reports 11.4% revenue growth in Q4, beating estimates with $7.17B

Stryker reported Q4 revenues of $7.17 billion, up 11.4% year-over-year and exceeding analyst expectations by 0.8%. The medical device manufacturer, which impacts over 150 million patients annually through its orthopaedics, surgical tools, neurotechnology and patient care solutions, delivered what CEO Kevin Lobo called "an outstanding finish to 2025". The company achieved double-digit sales and adjusted earnings per share growth for both the quarter and full year, whilst expanding adjusted operating margin by at least 100 basis points for the second consecutive year. Across the medical devices and supplies sector, the six diversified stocks tracked reported mixed Q4 results. As a group, revenues beat consensus estimates by 1.9%, though share prices have declined an average of 5.1% since the latest earnings announcements.

INACTIVE